Efficacy News and Research

RSS

How does Omicron BA.1 infection impact the risk of reinfection with BA.5?

Researchers found prior exposure to SARS-CoV-2 Omicron sub-variants BA.1/BA.2 reduced the risk of breakthrough infection by its sub-variant BA.5.

2 Aug 2022

The time has come for DIY mandates on covid

Here we are in the grip of yet another covid-19 surge, yet most people I see out and about are behaving as if the pandemic is over. And I live in Los Angeles County, whose public health department is arguably one of the most vigilant and proactive in the U.S.

2 Aug 2022

What is the efficacy of COVID-19 BNT162b2 and mRNA-1273 booster vaccinations?

In a new study, scientists compared the effectiveness of the SARS-CoV-2 BNT162b2 and mRNA-1273 vaccines booster doses in England.

2 Aug 2022

Study suggests peimine may be a potent inhibitor of SARS-CoV-2 variant infection

A recent study published in the Journal of Food Biochemistry discovered that peimine from Fritillaria might be a possible SARS-CoV-2 variant infection inhibitor.

2 Aug 2022

mRNA vaccines induce faster antibody response against infectious diseases

A new study describes that mRNA vaccines induce antigen-specific antibody response within a very short period of time after immunization.

2 Aug 2022

The efficacy of honokiol in inhibiting SARS-CoV-2 replication in cell culture

Researchers evaluated the efficacy of honokiol in inhibiting SARS-CoV-2 replication in cell cultures.

2 Aug 2022

Reduced severity of COVID-19 in pregnant women during the Omicron wave

A new study assesses the clinical outcomes of COVID-19 in pregnant women to determine whether Omicron and vaccination status impacted disease severity.

1 Aug 2022

CDC study describes safety profile of second mRNA COVID booster

The CDC investigates the safety profile of a fourth dose of mRNA-based COVID-19 vaccines in people aged 50 years and older.

1 Aug 2022

New smartphone app found to be successful in helping UK veterans to reduce alcohol consumption

A new smartphone app, which has been made available to the public today, has been found to be successful in helping UK veterans to reduce alcohol consumption.

1 Aug 2022

Study: SARS-CoV-2 variants of concern and biological sex of patients affect molnupiravir efficacy

SARS-CoV-2 variants of concern and the biological sex of patients affect the efficacy of molnupiravir, the first orally available drug approved for outpatient use against COVID-19, according to a new study led by researchers in the Center for Translational Antiviral Research in the Institute for Biomedical Sciences at Georgia State University.

1 Aug 2022

What is the safety of Molnupiravir against SARS-CoV-2 in the elderly?

A new study assessed the safety of the oral administration of Molnupiravir to elderly patients––aged 80 or older, hospitalized with COVID-19.

1 Aug 2022

ALZ-NET: First data collection and sharing network for new FDA-approved Alzheimer's treatments

ALZ-NET is the first network developed specifically for new FDA-approved Alzheimer's treatments, collecting real-world evidence on drug effectiveness and side effects over a long period of time.

1 Aug 2022

The recent progress in investigating the inhibitory impact of nanosponges and antiviral delivery against SARS-CoV-2

Researchers assessed the potential of nanosponges against SARS-CoV-2.

1 Aug 2022

Study finds a column containing a Galanthus nivalis agglutinin affinity resin can bind all the major COVID-19 variants

Researchers assessed the binding of Galanthus nivalis agglutinin to SARS-CoV-2 variants.

1 Aug 2022

Study indicates that cross-reactive immunity against SARS-CoV-2 N protein was present in Africa prior to the pandemic

Researchers assessed the pre-existing cross-protective immune responses against SARS-CoV-2 nucleocapsid protein and spike protein before the COVID-19 pandemic in individuals residing in North and South America, Europe and Africa in vitro and in vivo.

1 Aug 2022

Decoy ACE2 receptors broadly neutralize SARS-CoV-2 variants

Researchers review current developments in preclinical studies associated with recombinant ACE2 decoy receptors against coronaviruses.

31 Jul 2022

Researchers use a tumor organoid system to examine bacterial effects on immunotherapy

Wake Forest Institute for Regenerative Medicine researchers are using a tumor organoid system to examine the effects of metabolites secreted by bacteria on a specialized immunotherapy – immune checkpoint blockage, a promising cancer treatment development – to determine why some patients don't respond or develop a resistance to the treatment over time.

29 Jul 2022

Study aims to investigate the effects of digital diabetes prevention program on weight, physical activity

JMIR Publications recently published "A 12-Month Follow-Up of the Effects of a Digital Diabetes Prevention Program (VP Transform for Prediabetes) on Weight and Physical Activity Among Adults With Prediabetes: Secondary Analysis" in JMIR Diabetes which reported that previous research has demonstrated the efficacy of a diabetes prevention program (DPP) in lifestyle modifications that can prevent or delay the onset of type 2 diabetes among individuals at risk.

29 Jul 2022

Study examines the feasibility of patient engagement with digital life coaching during stem cell transplant

JMIR Publications recently published "Digital Life Coaching During Stem Cell Transplantation: Development and Usability Study" in JMIR Formative Research which reported that the authors launched a single-arm pilot study to investigate the feasibility of patient engagement with digital life coaching (DLC) during this intensive period.

29 Jul 2022

Celebrating the role of aspirin as chemopreventative agent against cancer

A special edition issue of the Aspirin Summaries has been published '125 years of aspirin - the role of aspirin in cancer' issue 2022.

29 Jul 2022

Efficacy News and Research

How does Omicron BA.1 infection impact the risk of reinfection with BA.5?

The time has come for DIY mandates on covid

What is the efficacy of COVID-19 BNT162b2 and mRNA-1273 booster vaccinations?

Study suggests peimine may be a potent inhibitor of SARS-CoV-2 variant infection

mRNA vaccines induce faster antibody response against infectious diseases

The efficacy of honokiol in inhibiting SARS-CoV-2 replication in cell culture

Reduced severity of COVID-19 in pregnant women during the Omicron wave

CDC study describes safety profile of second mRNA COVID booster

New smartphone app found to be successful in helping UK veterans to reduce alcohol consumption

Study: SARS-CoV-2 variants of concern and biological sex of patients affect molnupiravir efficacy

What is the safety of Molnupiravir against SARS-CoV-2 in the elderly?

ALZ-NET: First data collection and sharing network for new FDA-approved Alzheimer's treatments

The recent progress in investigating the inhibitory impact of nanosponges and antiviral delivery against SARS-CoV-2

Study finds a column containing a Galanthus nivalis agglutinin affinity resin can bind all the major COVID-19 variants

Study indicates that cross-reactive immunity against SARS-CoV-2 N protein was present in Africa prior to the pandemic

Decoy ACE2 receptors broadly neutralize SARS-CoV-2 variants

Researchers use a tumor organoid system to examine bacterial effects on immunotherapy

Study aims to investigate the effects of digital diabetes prevention program on weight, physical activity

Study examines the feasibility of patient engagement with digital life coaching during stem cell transplant

Celebrating the role of aspirin as chemopreventative agent against cancer

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News